TickerFactsScreenerDevelopers

Travere Therapeutics, Inc. (TVTX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2011: -$6892012: -$2.74M2015: -$1.39M2016: -$3.44M2017: $7.40M2018: -$24.96M2019: -$58.21M2020: -$42.74M2021: -$14.79M2022: -$186.29M2023: -$280.02M2024: -$237.47M2025: $37.78M$37.78M
2011Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$37.78M+115.9%
2024-$237.47M+15.2%
2023-$280.02M-50.3%
2022-$186.29M-1159.4%
2021-$14.79M+65.4%
2020-$42.74M+26.6%
2019-$58.21M-133.2%
2018-$24.96M-437.1%
2017$7.40M+315.1%
2016-$3.44M-147.7%
2015-$1.39M—
2012-$2.74M-397104.5%
2011-$689—